Echo Street Capital Management LLC Alnylam Pharmaceuticals, Inc. Transaction History

Echo Street Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$182.66 - $235.53 $234,170 - $301,949	1,282 New	1,282 $256,000
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $253,002 - $355,678	-2,101 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $232,739 - $318,255	-1,830 Reduced 46.55%	2,101 $343,000
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $336,831 - $441,811	2,111 Added 115.99%	3,931 $667,000
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $308,945 - $378,068	1,820 New	1,820 $344,000
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $388,333 - $534,030	-3,019 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$126.83 - $175.69 $131,015 - $181,487	1,033 Added 52.01%	3,019 $426,000
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $244,218 - $291,942	1,986 New	1,986 $258,000

642

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.